Article
Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.
International journal of antimicrobial agents - 1 Oct 2014
Marcusson Linda L, Komp Lindgren Patricia, Olofsson Sara K, Hughes Diarmaid, Cars Otto
Abstract excerpt
Pharmacodynamic and mutant prevention properties of the fluoroquinolone pradofloxacin (PRA) were measured against a set of 17 Escherichia coli strains carrying no, one or two known mutations conferring reduced fluoroquinolone susceptibility. The strains included susceptible wild-types, isogenic constructed mutants, isogenic selected mutants and clinical isolates. The effectiveness of PRA was determined with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
